We are live on ! Find out more
ZOM

Zomedica Corp.

Delisted

ZOM was delisted on the 4th of March, 2025.

23 hedge funds and large institutions have $387K invested in Zomedica Corp. in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 72 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

75% less funds holding

Funds holding: 9323 (-70)

96% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 72

97% less capital invested

Capital invested by funds: $11.1M → $387K (-$10.7M)

Holders
23
Holders Change
-70
Holders Change %
-75.27%
% of All Funds
0.31%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
2
Reduced
1
Closed
72
Calls
Puts
Net Calls
Net Calls Change

ZOM Hedge Fund Activity: Q1 2025 in Review

23 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q1 2025, worth a combined $387K — down 97% from $11.1M a quarter earlier.

Sellers outnumbered buyers: 72 funds closed out of ZOM and 3 opened new positions — a net loss of 69 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was Ancora Advisors, opening a new position worth an estimated $578K. The largest seller was Vanguard Group, exiting entirely with an estimated $5.77M sold.

  • 23 institutional investors held Zomedica Corp. (ZOM) as of Q1 2025, down from 93 in Q4 2024.
  • Funds reported $387K of Zomedica Corp. stock for Q1 2025, down 97% quarter-over-quarter.
  • 3 funds opened new Zomedica Corp. positions in Q1 2025 and 72 closed out, a net change of -69 holders.
  • The largest Zomedica Corp. buyer in Q1 2025 was Ancora Advisors, an estimated $578K added.
  • The largest Zomedica Corp. seller in Q1 2025 was Vanguard Group, an estimated $5.77M sold.

Based on aggregated 13F filings for Q1 2025.